Richard D. Moore
#127,341
Most Influential Person Now
Richard D. Moore's AcademicInfluence.com Rankings
Richard D. Mooremedical Degrees
Medical
#2053
World Rank
#2447
Historical Rank
Public Health
#288
World Rank
#299
Historical Rank
Epidemiology
#346
World Rank
#364
Historical Rank
Richard D. Mooremathematics Degrees
Mathematics
#6123
World Rank
#8540
Historical Rank
Control Theory
#34
World Rank
#36
Historical Rank
Statistics
#525
World Rank
#604
Historical Rank
Download Badge
Medical Mathematics
Richard D. Moore's Degrees
- PhD Biostatistics University of California, Berkeley
- Masters Biostatistics University of California, Berkeley
- Bachelors Mathematics University of California, Berkeley
Similar Degrees You Can Earn
Why Is Richard D. Moore Influential?
(Suggest an Edit or Addition)Richard D. Moore's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada (2013) (1190)
- Effect of early versus deferred antiretroviral therapy for HIV on survival. (2009) (1170)
- Hepatitis C and progression of HIV disease. (2002) (497)
- Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. (2012) (475)
- The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States (2006) (446)
- CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. (2007) (419)
- Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. (2003) (385)
- Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic (2002) (331)
- Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia [see comments] (1992) (330)
- The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil (2007) (327)
- Hazardous Alcohol Use: A Risk Factor for Non-Adherence and Lack of Suppression in HIV Infection (2006) (310)
- Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment. (2005) (304)
- Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV? (2006) (286)
- Racial and Gender Disparities in Receipt of Highly Active Antiretroviral Therapy Persist in a Multistate Sample of HIV Patients in 2001 (2005) (284)
- Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study (2004) (278)
- Detrimental Effects of Continued Illicit Drug Use on the Treatment of HIV‐1 Infection (2001) (273)
- Elevated incidence of lung cancer among HIV-infected individuals. (2006) (258)
- Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. (2015) (240)
- Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems. (2008) (224)
- A Multicenter Study of Physician Mindfulness and Health Care Quality (2013) (218)
- Late presentation for human immunodeficiency virus care in the United States and Canada. (2010) (215)
- Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy. (2004) (212)
- Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV. (2012) (207)
- Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. (2008) (207)
- Immune Reconstitution Inflammatory Syndrome: Risk Factors and Treatment Implications (2007) (204)
- Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults (2007) (202)
- Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. (2009) (200)
- Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada. (2016) (198)
- Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. (2006) (195)
- Characteristics, Diagnosis, and Treatment of Alcoholism in Elderly Patients (1989) (194)
- Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals (2008) (194)
- Invasive Cervical Cancer Risk Among HIV-Infected Women: A North American Multicohort Collaboration Prospective Study (2013) (193)
- Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus (2005) (190)
- Stability of the latent reservoir for HIV-1 in patients receiving valproic acid. (2007) (190)
- Neurosyphilis in a clinical cohort of HIV-1-infected patients (2008) (190)
- Predictive Accuracy of the Veterans Aging Cohort Study Index for Mortality With HIV Infection: A North American Cross Cohort Analysis (2013) (189)
- Clostridium difficile Colitis: An Efficient Clinical Approach to Diagnosis (1995) (187)
- Contemporary costs of HIV healthcare in the HAART era (2010) (186)
- Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir (2004) (186)
- Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). (2007) (178)
- Random survival forests for competing risks. (2014) (173)
- Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy. (2006) (167)
- Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda (2003) (165)
- Hospital and Outpatient Health Services Utilization Among HIV-Infected Adults in Care 2000–2002 (2005) (163)
- Anemia in HIV-infected patients receiving highly active antiretroviral therapy. (2002) (155)
- Higher Quality Communication and Relationships Are Associated With Improved Patient Engagement in HIV Care (2013) (155)
- End-stage renal disease among HIV-infected adults in North America. (2015) (151)
- Substance Abuse and Psychiatric Disorders in HIV-Positive Patients (2012) (148)
- Establishment, Retention, and Loss to Follow-Up in Outpatient HIV Care (2012) (146)
- Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection. (2009) (146)
- HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy (2001) (145)
- Influence of Lifestyle Modification in Renal Transplant Recipients With Postprandial Hyperglycemia (2008) (145)
- Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic (2006) (145)
- Multi-step inhibition explains HIV-1 protease inhibitor pharmacodynamics and resistance. (2013) (142)
- Enhanced personal contact with HIV patients improves retention in primary care: a randomized trial in 6 US HIV clinics. (2014) (140)
- Renal function with use of a tenofovir-containing initial antiretroviral regimen (2009) (140)
- The Economic Burden of Late Entry Into Medical Care for Patients With HIV Infection (2010) (136)
- Retention Among North American HIV-Infected Persons in Clinical Care, 2000–2008 (2013) (135)
- Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups. (2006) (135)
- Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era. (2013) (134)
- Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy. (2011) (134)
- Risk of Non-AIDS-Related Mortality May Exceed Risk of AIDS-Related Mortality Among Individuals Enrolling Into Care With CD4+ Counts Greater Than 200 Cells/mm3 (2007) (134)
- Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts. (2006) (133)
- Delayed Diagnosis and Elevated Mortality in an Urban Population With HIV and Lung Cancer: Implications for Patient Care (2006) (133)
- Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification (2008) (132)
- End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004 (2007) (130)
- Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality. (2014) (130)
- Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care (2012) (129)
- The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection (2005) (128)
- Trust in physicians and racial disparities in HIV care. (2010) (127)
- Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. (2002) (125)
- Community-acquired pneumonia: impact of immune status. (1995) (124)
- Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda. (2006) (124)
- Epidemiology of HIV infection in the United States: implications for linkage to care. (2011) (118)
- Greater effect of highly active antiretroviral therapy on survival in people aged > or =50 years compared with younger people in an urban observational cohort. (2003) (117)
- Comparing different measures of retention in outpatient HIV care (2012) (116)
- Clinic-Based Treatment of Opioid-Dependent HIV-Infected Patients Versus Referral to an Opioid Treatment Program (2010) (116)
- Multimorbidity Among Persons Living with Human Immunodeficiency Virus in the United States (2018) (115)
- Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010. (2016) (114)
- Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy. (2013) (112)
- Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. (2001) (111)
- The Incidence of, Risk Factors for, and Sequelae of Herpes Zoster Among HIV Patients in the Highly Active Antiretroviral Therapy Era (2005) (111)
- Hospitalizations for Metabolic Conditions, Opportunistic Infections, and Injection Drug Use Among HIV Patients: Trends Between 1996 and 2000 in 12 States (2005) (110)
- An Improvement in Virologic Response to Highly Active Antiretroviral Therapy in Clinical Practice From 1996 Through 2002 (2005) (108)
- U.S. Trends in Antiretroviral Therapy Use, HIV RNA Plasma Viral Loads, and CD4 T-Lymphocyte Cell Counts Among HIV-Infected Persons, 2000 to 2008 (2012) (106)
- Trends in Reasons for Hospitalization in a Multisite United States Cohort of Persons Living With HIV, 2001–2008 (2012) (104)
- Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada (2020) (104)
- Lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms. (2009) (103)
- The Effect of HAART and HCV Infection on the Development of Hyperglycemia Among HIV‐Infected Persons (2003) (102)
- The Lifetime Medical Cost Savings From Preventing HIV in the United States (2015) (101)
- Assessing and Refining Myocardial Infarction Risk Estimation Among Patients With Human Immunodeficiency Virus: A Study by the Centers for AIDS Research Network of Integrated Clinical Systems (2017) (99)
- Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: longer follow-up of an observational cohort study. (2003) (99)
- Immunologic and Virologic Predictors of AIDS-Related Non-Hodgkin Lymphoma in the Highly Active Antiretroviral Therapy Era (2009) (99)
- Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: Prospective analysis of 435 liver biopsy pairs (2014) (97)
- Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. (2013) (96)
- A low-effort, clinic-wide intervention improves attendance for HIV primary care. (2012) (96)
- Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs (2018) (96)
- Hospitalization Rates Differ by Hepatitis C Status in an Urban HIV Cohort (2003) (94)
- Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population (2017) (94)
- Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients. (2008) (94)
- Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection. (2015) (91)
- Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study. (2004) (90)
- Differences in HIV Disease Progression by Injecting Drug Use in HIV-Infected Persons in Care (2004) (90)
- Racial and Ethnic Differences in Outcome in Zidovudine-Treated Patients With Advanced HIV Disease (1991) (90)
- Primary Care Provider Cultural Competence and Racial Disparities in HIV Care and Outcomes (2013) (90)
- Cost‐effectiveness of hydroxyurea in sickle cell anemia (2000) (90)
- Patient–Provider Communication Differs for Black Compared to White HIV-Infected Patients (2011) (89)
- Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource‐limited settings (2003) (88)
- Effect of age and HAART regimen on clinical response in an urban cohort of HIV-infected individuals (2008) (86)
- CD4 count at presentation for HIV care in the United States and Canada: Are those over 50 years more likely to have a delayed presentation? (2010) (86)
- Association of Increased Chronicity of Depression With HIV Appointment Attendance, Treatment Failure, and Mortality Among HIV-Infected Adults in the United States (2018) (86)
- Clinician empathy is associated with differences in patient-clinician communication behaviors and higher medication self-efficacy in HIV care. (2016) (85)
- Genotypic resistance in HIV-1-infected patients with persistently detectable low-level viremia while receiving highly active antiretroviral therapy. (2004) (85)
- HIV Viral Suppression Trends Over Time Among HIV-Infected Patients Receiving Care in the United States, 1997 to 2015 (2018) (84)
- Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care (2011) (83)
- Sustained viral suppression in HIV-infected patients receiving antiretroviral therapy. (2012) (81)
- Kidney function and the risk of cardiovascular events in HIV-1-infected patients (2010) (81)
- Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals. (2014) (79)
- Impact of Age on Retention in Care and Viral Suppression (2015) (78)
- Association between Use of HMG CoA Reductase Inhibitors and Mortality in HIV-Infected Patients (2011) (78)
- Improvement in the health of HIV-infected persons in care: reducing disparities. (2012) (78)
- Differences in Patient–Provider Communication for Hispanic Compared to Non-Hispanic White Patients in HIV Care (2010) (77)
- Incidence of, Risk Factors for, Clinical Presentation, and 1-Year Outcomes of Infective Endocarditis in an Urban HIV Cohort (2006) (77)
- Heavy Alcohol Use Is Associated With Worse Retention in HIV Care (2016) (76)
- Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies. (2019) (76)
- Internet health information seeking behavior and antiretroviral adherence in persons living with HIV/AIDS. (2011) (75)
- Performance of a Limiting-Antigen Avidity Enzyme Immunoassay for Cross-Sectional Estimation of HIV Incidence in the United States (2013) (74)
- Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras. (2016) (74)
- Immune status at presentation to care did not improve among antiretroviral-naive persons from 1990 to 2006. (2007) (73)
- Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden? (2002) (72)
- Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil (2008) (71)
- Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy. (2013) (69)
- Early mortality and cause of deaths in patients using HAART in Brazil and the United States (2009) (69)
- Elite Controllers are Hospitalized More Often than Persons with Medically Controlled HIV (2014) (68)
- Rapid Communication Hospital and Outpatient Health Services Utilization Among HIV‐Infected Patients in Care in 1999 (2002) (67)
- Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990–2003 (2006) (66)
- The HIV Care Continuum: Changes over Time in Retention in Care and Viral Suppression (2015) (66)
- Does the Presence of a Current Psychiatric Disorder in AIDS Patients Affect the Initiation of Antiretroviral Treatment and Duration of Therapy? (2004) (65)
- HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers (2016) (65)
- Alcohol consumption among HIV-infected women: impact on time to antiretroviral therapy and survival. (2011) (65)
- Herpes Zoster Among Persons Living With HIV in the Current Antiretroviral Therapy Era (2012) (64)
- Aging and loss to follow-up among youth living with human immunodeficiency virus in the HIV Research Network. (2015) (64)
- Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. (2009) (64)
- Reduced Risk of Prostate Cancer in U.S. Men with AIDS (2010) (63)
- Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status. (2008) (62)
- Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. (2014) (62)
- Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapy (2003) (61)
- Time above 1500 copies: a viral load measure for assessing transmission risk of HIV-positive patients in care (2015) (60)
- Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America (2017) (59)
- High Levels of Antiretroviral Use and Viral Suppression Among Persons in HIV Care in the United States, 2010 (2013) (58)
- Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution (2009) (57)
- HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use (2009) (57)
- Survival in an Urban HIV‐1 Clinic in the Era of Highly Active Antiretroviral Therapy: A 5‐Year Cohort Study (2003) (56)
- Absolute CD4 Vs. CD4 Percentage for Predicting the Risk of Opportunistic Illness in HIV Infection (2004) (56)
- Types of Myocardial Infarction Among Human Immunodeficiency Virus–Infected Individuals in the United States (2017) (55)
- Provision of general and HIV-specific health maintenance in middle aged and older patients in an urban HIV clinic. (2006) (55)
- Lower-Sensitivity and Avidity Modifications of the Vitros Anti-HIV 1+2 Assay for Detection of Recent HIV Infections and Incidence Estimation (2012) (54)
- HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy—Results From the IeDEA Collaboration (2017) (54)
- Venous Thromboembolism in Patients With HIV/AIDS: A Case-Control Study (2008) (54)
- Interval and clinical cohort studies: epidemiological issues. (2007) (54)
- Dramatic decline in the HIV-1 RNA level over calendar time in a large urban HIV practice. (2011) (54)
- Association of medical insurance and other factors with receipt of antiretroviral therapy. (2002) (54)
- Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing (2004) (52)
- Initiation of highly active antiretroviral therapy at CD4+ T lymphocyte counts of >350 cells/mm3: disease progression, treatment durability, and drug toxicity. (2003) (52)
- Incidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus. (2011) (51)
- Inpatient Health Services Utilization Among HIV-Infected Adult Patients in Care 2002–2007 (2010) (51)
- Impact of a brief patient and provider intervention to improve the quality of communication about medication adherence among HIV patients. (2015) (51)
- Longitudinal study reveals HIV-1-infected CD4+ T cell dynamics during long-term antiretroviral therapy. (2020) (51)
- Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals. (2013) (50)
- Race, Relationships and Trust in Providers among Black Patients with HIV/AIDS. (2013) (50)
- Clostridium difficile in a HIV-infected cohort: incidence, risk factors, and clinical outcomes (2013) (50)
- Structures of care in the clinics of the HIV Research Network. (2008) (50)
- Lack of sex difference in CD4 to HIV-1 RNA viral load ratio (1999) (49)
- Long-term cocaine use and antiretroviral therapy are associated with silent coronary artery disease in African Americans with HIV infection who have no cardiovascular symptoms. (2008) (48)
- Low level viremia and virologic failure in persons with HIV infection treated with antiretroviral therapy. (2019) (47)
- The role of cultural distance between patient and provider in explaining racial/ethnic disparities in HIV care. (2011) (47)
- Providing support to patients in emotional encounters: a new perspective on missed empathic opportunities. (2012) (47)
- First Occurrence of Diabetes, Chronic Kidney Disease, and Hypertension Among North American HIV-Infected Adults, 2000–2013 (2016) (47)
- Geographic Variations in Retention in Care among HIV-Infected Adults in the United States (2016) (47)
- HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy. (2014) (46)
- Pneumocystis Prophylaxis and Survival in Patients With Advanced Human Immunodeficiency Virus Infection Treated With Zidovudine (1992) (46)
- Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis (2016) (46)
- Drug Use and Receipt of Highly Active Antiretroviral Therapy among HIV-Infected Persons in Two U.S. Clinic Cohorts (2011) (46)
- Prospective CT Screening for Lung Cancer in a High-Risk Population: HIV-Positive Smokers (2014) (45)
- Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration (2014) (45)
- Long-term Safety and Efficacy of Zidovudine in Patients With Advanced Human Immunodeficiency Virus Disease (1991) (44)
- Age at Entry Into Care, Timing of Antiretroviral Therapy Initiation, and 10-Year Mortality Among HIV-Seropositive Adults in the United States. (2015) (44)
- Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV (2018) (43)
- Changing Predictors of Mortality Over Time From cART Start: Implications for Care (2011) (43)
- Use of a High Resolution Melting (HRM) Assay to Compare Gag, Pol, and Env Diversity in Adults with Different Stages of HIV Infection (2011) (42)
- The Impact of Youth-Friendly Structures of Care on Retention Among HIV-Infected Youth. (2016) (42)
- A longitudinal, HIV care continuum: 10-year restricted mean time in each care continuum stage after enrollment in care, by history of IDU (2016) (41)
- Disparities in Receipt of Antiretroviral Therapy Among HIV-infected Adults (2002–2008) (2012) (41)
- Retention in care and health outcomes of transgender persons living with HIV. (2013) (40)
- Antiretroviral medication errors remain high but are quickly corrected among hospitalized HIV-infected adults. (2012) (40)
- Incidence of modifying or discontinuing first HAART regimen and its determinants in a cohort of HIV-infected patients from Rio de Janeiro, Brazil. (2010) (40)
- A ten-year analysis of the incidence and risk factors for acute pancreatitis requiring hospitalization in an urban HIV clinical cohort. (2008) (40)
- Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy. (2007) (40)
- Effect of Natural and ARV-Induced Viral Suppression and Viral Breakthrough on Anti-HIV Antibody Proportion and Avidity in Patients with HIV-1 Subtype B Infection (2013) (40)
- Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study. (2019) (39)
- Collaborative, pooled and harmonized study designs for epidemiologic research: challenges and opportunities. (2018) (39)
- Medication adherence in HIV-positive patients with diabetes or hypertension: a focus group study (2013) (39)
- Immune Status at Presentation for HIV Clinical Care in Rio de Janeiro and Baltimore (2011) (38)
- Substance Use and the Quality of Patient-Provider Communication in HIV Clinics (2011) (38)
- Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. (2011) (38)
- Lymphoma immune reconstitution inflammatory syndrome in the center for AIDS research network of integrated clinical systems cohort. (2014) (38)
- Association of early HIV viremia with mortality after HIV-associated lymphoma (2013) (37)
- Clinical and mental health correlates and risk factors for intimate partner violence among HIV-positive women in an inner-city HIV clinic. (2012) (37)
- Cancer burden attributable to cigarette smoking among HIV-infected people in North America (2017) (37)
- Disparities in Depressive Symptoms and Antidepressant Treatment by Gender and Race/Ethnicity among People Living with HIV in the United States (2016) (37)
- Respecting patients is associated with more patient-centered communication behaviors in clinical encounters. (2016) (36)
- HIV Infection Itself May Not Be Associated With Subclinical Coronary Artery Disease Among African Americans Without Cardiovascular Symptoms (2016) (36)
- Barriers to recommended gynecologic care in an urban United States HIV clinic. (2010) (36)
- HIV-related medical service use by rural/urban residents: a multistate perspective (2011) (35)
- Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy. (2016) (35)
- A Comparison of Two Measures of HIV Diversity in Multi-Assay Algorithms for HIV Incidence Estimation (2014) (35)
- Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland. (2007) (35)
- HIV primary care providers--Screening, knowledge, attitudes and behaviors related to alcohol interventions. (2016) (35)
- Long-term combination antiretroviral therapy is associated with the risk of coronary plaques in African Americans with HIV infection. (2009) (34)
- Decision-Making Role Preferences Among Patients with HIV: Associations with Patient and Provider Characteristics and Communication Behaviors (2010) (34)
- Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV Treatment (2016) (34)
- Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada (2017) (34)
- Cervical cancer risk in women living with HIV across four continents: A multicohort study (2020) (34)
- A qualitative study of barriers to and facilitators of optimal engagement in care among PLWH and substance use/misuse (2016) (34)
- A mixed methods study of patient-provider communication about opioid analgesics. (2015) (33)
- Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study (2017) (33)
- Human immunodeficiency virus infection as a prognostic factor in surgical patients with non-small cell lung cancer. (2012) (33)
- Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States. (2016) (32)
- Risk of Incident Diabetes Mellitus, Weight Gain, and their Relationships with Integrase Inhibitor-based Initial Antiretroviral Therapy Among Persons with HIV in the US and Canada. (2020) (31)
- Is Patients’ Preferred Involvement in Health Decisions Related to Outcomes for Patients with HIV? (2007) (30)
- Evaluation of Dynabeads and Cytospheres Compared With Flow Cytometry to Enumerate CD4+ T Cells in HIV-Infected Ugandans on Antiretroviral Therapy (2008) (30)
- Ten-year Survival by Race/Ethnicity and Sex Among Treated, HIV-infected Adults in the United States. (2015) (30)
- High Rates of Primary Mycobacterium avium Complex and Pneumocystis jiroveci Prophylaxis in the United States (2005) (30)
- Coronary artery endothelial dysfunction is present in HIV-positive individuals without significant coronary artery disease (2017) (29)
- Control of Medical Comorbidities in Individuals With HIV (2011) (29)
- When to Censor? (2018) (29)
- Interaction Between Alcohol Consumption Patterns, Antiretroviral Therapy Type, and Liver Fibrosis in Persons Living with HIV. (2016) (28)
- The association of clinical follow-up intervals in HIV-infected persons with viral suppression on subsequent viral suppression. (2013) (28)
- Comparison of Clinical Response to Initial Highly Active Antiretroviral Therapy in the Patients in Clinical Care in the United States and Brazil (2007) (28)
- Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical Cohort (2017) (28)
- AIDS-Related Tuberculosis in Rio de Janeiro, Brazil (2008) (28)
- Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection. (2011) (28)
- Characterizing the Human Immunodeficiency Virus Care Continuum Among Transgender Women and Cisgender Women and Men in Clinical Care: A Retrospective Time-series Analysis. (2019) (27)
- Association between U.S. State AIDS Drug Assistance Program (ADAP) Features and HIV Antiretroviral Therapy Initiation, 2001–2009 (2013) (27)
- Incidence and Natural History of Cytomegalovirus Disease in Patients With Advanced Human Immune Deficiency Virus Disease Treated With Zidovudine: The Zidovudine Epidemiology Study Group (1993) (27)
- Coronary Endothelial Dysfunction Is Associated With Elevated Serum PCSK9 Levels in People With HIV Independent of Low‐Density Lipoprotein Cholesterol (2018) (26)
- Thirty-day hospital readmission rate among adults living with HIV (2013) (26)
- Are Smokers with HIV Using Information and Communication Technology? Implications for Behavioral Interventions (2012) (25)
- An application of restricted mean survival time in a competing risks setting: comparing time to ART initiation by injection drug use (2018) (25)
- Associations between outpatient and inpatient service use among persons with HIV infection: a positive or negative relationship? (2007) (25)
- Risk Factors for Kaposi's Sarcoma in Patients With Advanced Human Immunodeficiency Virus Disease Treated With Zidovudine (1994) (25)
- Strong Agreement of Nationally Recommended Retention Measures from the Institute of Medicine and Department of Health and Human Services (2014) (25)
- Gonorrhoea and chlamydia testing rates of HIV-infected men: low despite guidelines (2010) (24)
- Healthcare Coverage for HIV Provider Visits Before and After Implementation of the Affordable Care Act. (2016) (24)
- Impact of Hepatitis Coinfection on Healthcare Utilization Among Persons Living With HIV (2015) (24)
- HIV Diversity as a Biomarker for HIV Incidence Estimation: Including a High-Resolution Melting Diversity Assay in a Multiassay Algorithm (2013) (24)
- Alcohol Consumption and CD4 T-Cell Count Response Among Persons Initiating Antiretroviral Therapy (2012) (23)
- The HIV Research Network: a unique opportunity for real time clinical utilization analysis in HIV. (2003) (23)
- Impact of Patient Race on Patient Experiences of Access and Communication in HIV Care (2008) (23)
- Provider–Patient Communication About Adherence to Anti-retroviral Regimens Differs by Patient Race and Ethnicity (2014) (23)
- HIV women's health: a study of gynecological healthcare service utilization in a U.S. urban clinic population. (2008) (23)
- Impact of the 1993 revision of the AIDS case definition on the prevalence of AIDS in a clinical setting (1993) (23)
- Influence of Substance Use Disorders on 2-Year HIV Care Retention in the United States (2018) (23)
- Evaluating competing adverse and beneficial outcomes using a mixture model (2008) (23)
- Factors Associated With Delayed Hepatitis B Viral Suppression on Tenofovir Among Patients Coinfected With HBV-HIV in the CNICS Cohort (2014) (23)
- Life-Expectancy Disparities Among Adults With HIV in the United States and Canada: The Impact of a Reduction in Drug- and Alcohol-Related Deaths Using the Lives Saved Simulation Model (2019) (23)
- Barriers to Hepatitis C Virus (HCV) Treatment Initiation in Patients With Human Immunodeficiency Virus/HCV Coinfection: Lessons From the Interferon Era (2017) (23)
- Marijuana use and HIV treatment outcomes among PWH receiving care at an urban HIV clinic. (2017) (22)
- Laboratory Measures as Proxies for Primary Care Encounters: Implications for Quantifying Clinical Retention Among HIV-Infected Adults in North America. (2015) (22)
- Mind the Gap: Gaps in Antidepressant Treatment, Treatment Adjustments, and Outcomes among Patients in Routine HIV Care in a Multisite U.S. Clinical Cohort (2017) (22)
- Trends in antiretroviral therapy prescription, durability and modification: new drugs, more changes, but less failure (2017) (21)
- Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence (2014) (21)
- Improving Depression Among HIV-Infected Adults: Transporting the Effect of a Depression Treatment Intervention to Routine Care (2016) (21)
- Depressive Symptoms and Engagement in Human Immunodeficiency Virus Care Following Antiretroviral Therapy Initiation (2018) (20)
- Internalized HIV Stigma is Associated with Concurrent Viremia and Poor Retention in a Cohort of U.S. Patients in HIV Care (2019) (20)
- High-Risk Prescription Opioid Use Among People Living With HIV (2018) (19)
- Motivational interviewing by HIV care providers is associated with patient intentions to reduce unsafe sexual behavior. (2013) (19)
- Lack of Association between Acyclovir Use and Survival in Patients with Advanced Human Immunodeficiency Virus Disease Treated with Zidovudine (1995) (19)
- The impact of combined antiretroviral therapy on biologic false-positive rapid plasma reagin serologies in a longitudinal cohort of HIV-infected persons. (2013) (19)
- Failure to Identify HIV-Infected Individuals in a Clinical Trial Using a Single HIV Rapid Test for Screening (2014) (19)
- Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy. (2001) (19)
- Directly Administered Antiretroviral Therapy for HIV-Infected Individuals in Opioid Treatment Programs: Results from a Randomized Clinical Trial (2013) (18)
- Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS) (2019) (18)
- Factors Associated With Retention Among Non-Perinatally HIV-Infected Youth in the HIV Research Network. (2016) (18)
- The impact of depressive symptoms on patient–provider communication in HIV care (2013) (18)
- Loss to Clinic and Five-Year Mortality among HIV-Infected Antiretroviral Therapy Initiators (2014) (18)
- Increased gonorrhoea and chlamydia testing did not increase case detection in an HIV clinical cohort 1999–2007 (2011) (18)
- A Flow-Based Model of the HIV Care Continuum in the United States (2017) (18)
- Brief Report: Gonorrhea and Chlamydia Testing Increasing but Still Lagging in HIV Clinics in the United States (2015) (18)
- Association of immunosuppression and HIV viremia with anal cancer risk in persons living with HIV in the United States and Canada. (2019) (18)
- Physician specialization and women's primary care services in an urban HIV clinic. (2008) (18)
- Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, Brazil (2014) (17)
- Glycoproteomic Study Reveals Altered Plasma Proteins Associated with HIV Elite Suppressors (2014) (17)
- Counseling to reduce high-risk sexual behavior in HIV care: a multi-center, direct observation study. (2013) (17)
- Immune Status and Associated Mortality After Cancer Treatment Among Individuals With HIV in the Antiretroviral Therapy Era. (2019) (17)
- Long-Term CD4+ Cell Count in Response to Combination Antiretroviral Therapy (2014) (17)
- Current practices of screening for incident hepatitis C virus (HCV) infection among HIV-infected, HCV-uninfected individuals in primary care. (2014) (17)
- Incomplete viral suppression and mortality in HIV patients after antiretroviral therapy initiation (2017) (17)
- Vitamin D deficiency is associated with development of subclinical coronary artery disease in HIV-infected African American cocaine users with low Framingham-defined cardiovascular risk (2013) (17)
- Gonorrhea and Chlamydia Case Detection Increased When Testing Increased in a Multisite US HIV Cohort, 2004–2014 (2017) (17)
- Cocaine Abstinence and Reduced Use Associated With Lowered Marker of Endothelial Dysfunction in African Americans: A Preliminary Study (2015) (17)
- “We’ll Do this Together”: The Role of the First Person Plural in Fostering Partnership in Patient-physician Relationships (2010) (17)
- Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients (2019) (16)
- Vitamin D Deficiency and Its Relation to Bone Mineral Density and Liver Fibrosis in HIV–HCV Coinfection (2013) (16)
- Measurement of Current Substance Use in a Cohort of HIV-Infected Persons in Continuity HIV Care, 2007–2015 (2018) (16)
- Clinician Stress and Patient–Clinician Communication in HIV Care (2012) (16)
- Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015 (2021) (16)
- Multiple Imputation to Account for Measurement Error in Marginal Structural Models (2015) (16)
- A Case Series of 59 Patients with Nocardiosis (2001) (15)
- Rhabdomyolysis in an HIV cohort: epidemiology, causes and outcomes (2017) (15)
- Closing the Gap in Antiretroviral Initiation and Viral Suppression: Time Trends and Racial Disparities (2016) (15)
- Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014 (2017) (15)
- Risk of HCC With Hepatitis B Viremia Among HIV/HBV‐Coinfected Persons in North America (2021) (15)
- Hepatitis C Virus Testing in Adults Living with HIV: A Need for Improved Screening Efforts (2014) (15)
- Treatment of HIV infection in the older patient (2004) (15)
- Reduced Frequency of Cells Latently Infected With Replication-Competent Human Immunodeficiency Virus-1 in Virally Suppressed Individuals Living in Rakai, Uganda (2017) (15)
- HIV providers' perceptions of and attitudes toward female versus male patients. (2012) (14)
- Low-density lipoprotein cholesterol response after statin initiation among persons living with human immunodeficiency virus. (2018) (14)
- Systemic Elevation of Proinflammatory Interleukin 18 in HIV/HCV Coinfection versus HIV or HCV Monoinfection. (2016) (14)
- Hepatic Safety and Tolerability of Raltegravir among HIV Patients Coinfected with Hepatitis B And/Or C (2014) (14)
- The Relationship Between Efavirenz as Initial Antiretroviral Therapy and Suicidal Thoughts Among HIV-Infected Adults in Routine Care (2017) (14)
- Do Symptoms of Depression Interact with Substance Use to Affect HIV Continuum of Care Outcomes? (2018) (14)
- Ascertainment and Verification of End-Stage Renal Disease and End-Stage Liver Disease in the North American AIDS Cohort Collaboration on Research and Design (2015) (13)
- Gonorrhoea and chlamydia in persons with HIV: number needed to screen (2019) (13)
- Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada (2018) (13)
- Effectiveness of Direct-Acting Antiviral Therapy in Patients With Human Immunodeficiency Virus–Hepatitis C Virus Coinfection in Routine Clinical Care: A Multicenter Study (2019) (13)
- Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study. (2017) (13)
- Detecting Disengagement From HIV Care Before It Is Too Late: Development and Preliminary Validation of a Novel Index of Engagement in HIV Care (2019) (12)
- Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america. (2011) (12)
- HCV Screening and Treatment Uptake Among Patients in HIV Care During 2014–2015 (2019) (12)
- Testosterone replacement therapy among HIV-infected men in the CFAR Network of Integrated Clinical Systems (2015) (12)
- Combined estimation of disease progression and retention on antiretroviral therapy among treated individuals with HIV in the USA: a modelling study. (2019) (12)
- Neisseria gonorrhoeae and Chlamydia trachomatis among human immunodeficiency virus-infected women. (2008) (12)
- Association of injection drug use with incidence of HIV-associated non-AIDS-related morbidity by age, 1995–2014 (2016) (12)
- Identifying HIV care enrollees at-risk for cannabis use disorder (2017) (12)
- The Role of Current and Historical Alcohol Use in Hepatic Fibrosis Among HIV-Infected Individuals (2017) (12)
- Medicaid trends in prescription opioid and non-opioid use by HIV status. (2019) (12)
- Virologic suppression and CD4+ cell count recovery after initiation of raltegravir or efavirenz-containing HIV treatment regimens (2017) (11)
- One Size Fits (n)One: The Influence of Sex, Age, and Sexual Human Immunodeficiency Virus (HIV) Acquisition Risk on Racial/Ethnic Disparities in the HIV Care Continuum in the United States (2018) (11)
- Effects of Minimal Versus Intensive Intervention to Enhance Motivational Interviewing in HIV Care (2017) (11)
- Risks of recreational exposure to waterborne pathogens among persons with HIV/AIDS in Baltimore, Maryland. (2009) (11)
- Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV‐positive individuals (2019) (11)
- Cocaine use may modify HIV/ART-associated myocardial steatosis and hepatic steatosis. (2017) (11)
- The Depression Treatment Cascade: Disparities by Alcohol Use, Drug Use, and Panic Symptoms Among Patients in Routine HIV Care in the United States (2018) (11)
- Cumulative Human Immunodeficiency Viremia, Antiretroviral Therapy, and Incident Myocardial Infarction (2019) (11)
- Evaluation of Human Immunodeficiency Virus Biomarkers: Inferences From Interval and Clinical Cohort Studies (2009) (11)
- Reply to Gupta (2005) (11)
- Impact of abstinence and of reducing illicit drug use without abstinence on HIV viral load. (2020) (11)
- Recent Substance Use and Probability of Unsuppressed HIV Viral Load among Persons on Antiretroviral Therapy in Continuity Care. (2019) (11)
- CD4+ T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa (2015) (11)
- Factors Associated With Severity of COVID-19 Disease in a Multicenter Cohort of People With HIV in the United States, March–December 2020 (2022) (11)
- Combination Antiretroviral Therapy in HIV Infection (1996) (11)
- Incident AIDS or Death After Initiation of Human Immunodeficiency Virus Treatment Regimens Including Raltegravir or Efavirenz Among Adults in the United States (2017) (10)
- Outcomes of second combination antiretroviral therapy regimens among HIV-infected persons in clinical care: a multicenter cohort study. (2013) (10)
- Multimorbidity Among Persons Living with HIV in the U.S. (2017) (10)
- A qualitative study examining the benefits and challenges of incorporating patient-reported outcome substance use and mental health questionnaires into clinical practice to improve outcomes on the HIV care continuum (2018) (10)
- Implementation of a COPD Screening Questionnaire in an Outpatient HIV Clinic (2016) (10)
- Expenditures for Persons Living With HIV Enrolled in Medicaid, 2006–2010 (2016) (10)
- Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease (1998) (10)
- Predisposing Factors for Adrenal Insufficiency (2009) (10)
- Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020 (2021) (10)
- Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis (2018) (10)
- Regional differences in predictive accuracy of WHO immunologic failure criteria (2012) (9)
- Virologic failure among people living with HIV initiating dolutegravir-based versus other recommended regimens in real-world clinical care settings. (2017) (9)
- Natural history of advanced HIV disease in patients treated with zidovudane (1992) (9)
- Hepatitis C Elimination in People With HIV Is Contingent on Closing Gaps in the HIV Continuum (2019) (9)
- The shifting age distribution of people with HIV using antiretroviral therapy in the United States (2021) (9)
- Genetic architecture of cardiometabolic risks in people living with HIV (2020) (9)
- An Illustration of Inverse Probability Weighting to Estimate Policy-Relevant Causal Effects. (2016) (9)
- Assessing Problematic Substance Use in HIV Care: Which Questions Elicit Accurate Patient Disclosures? (2016) (9)
- Not all non-drinkers with HIV are equal: demographic and clinical comparisons among current non-drinkers with and without a history of prior alcohol use disorders* (2017) (9)
- Hepatic steatosis associated with increased central body fat by dual-energy X-ray absorptiometry and uncontrolled HIV in HIV/hepatitis C co-infected persons (2010) (9)
- Relationship between ever reporting depressive symptoms and all-cause mortality in a cohort of HIV-infected adults in routine care (2017) (9)
- Risk factors for delayed antiretroviral therapy initiation among HIV-seropositive patients (2017) (9)
- Which Clinician Questions Elicit Accurate Disclosure of Antiretroviral Non-adherence When Talking to Patients? (2016) (9)
- Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America (2016) (9)
- Cross-cohort heterogeneity encountered while validating a model for HIV disease progression among antiretroviral initiators. (2009) (9)
- Hospitalization Rates and Causes among Persons with HIV in the US and Canada, 2005-2015. (2020) (9)
- Hospitalization Rates and Causes among Persons with HIV in the US and Canada, 2005-2015. (2020) (9)
- Emotional Communication in HIV Care: An Observational Study of Patients’ Expressed Emotions and Clinician Response (2019) (9)
- Drug and alcohol use among people living with HIV in care in the United States by geographic region (2021) (8)
- Tobacco Smoking, Substance Use, and Mental Health Symptoms in People with HIV in an Urban HIV Clinic (2019) (8)
- Time Spent with HIV Viral Load > 1500 Copies/mL Among Persons Engaged in Continuity HIV Care in an Urban Clinic in the United States, 2010–2015 (2018) (8)
- Erratum: Lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms (Clin Infect Dis (2009) 48 (816-21)) (2009) (8)
- U.S. Hospitalization rates and reasons stratified by age among persons with HIV 2014–15 (2019) (8)
- Evaluating the Population Impact on Racial/Ethnic Disparities in HIV in Adulthood of Intervening on Specific Targets: A Conceptual and Methodological Framework (2018) (8)
- Patterns of Efavirenz use as First-Line Antiretroviral Therapy in the United States: 1999–2015 (2018) (8)
- Cancer risk in HIV patients with incomplete viral suppression after initiation of antiretroviral therapy (2018) (8)
- Internalized HIV Stigma Predicts Suboptimal Retention in Care Among People Living with HIV in the United States. (2021) (8)
- Mind the gap: observation windows to define periods of event ascertainment as a quality control method for longitudinal electronic health record data. (2019) (8)
- Timing of Antiretroviral Therapy Initiation and Risk of Cancer among Persons Living with HIV. (2020) (8)
- Compound Retention in Care and All-Cause Mortality Among Persons Living With Human Immunodeficiency Virus (2019) (8)
- Antibody Maturation and Viral Diversification in HIV-Infected Women (2013) (8)
- Mortality Among Persons Entering HIV Care Compared With the General U.S. Population (2021) (8)
- HIV viral suppression after transition from having no healthcare coverage and relying on Ryan White HIV/AIDS Program Support to Medicaid or private health insurance. (2019) (8)
- Timing of Antiretroviral Treatment, Immunovirologic Status, and TB Risk: Implications for Testing and Treatment (2016) (8)
- Cocaine use may induce telomere shortening in individuals with HIV infection (2018) (7)
- Variation in estimated viral suppression associated with the definition of viral suppression used. (2020) (7)
- Racial disparities in clinician responses to patient emotions. (2020) (7)
- Cross-reactive microbial peptides can modulate HIV-specific CD8+ T cell responses (2018) (7)
- Association of History of Injection Drug Use with External Cause-Related Mortality Among Persons Linked to HIV Care in an Urban Clinic, 2001–2015 (2019) (7)
- Desperate Times: Protecting the Public From Research Without Consent or Oversight During Public Health Emergencies (2020) (7)
- Multivariate estimation of cumulative incidence, prevalence, and morbidity time of a disease when death is likely. (2003) (7)
- Viral suppression among persons in HIV care in the United States during 2009-2013: sampling bias in Medical Monitoring Project surveillance estimates. (2019) (7)
- Cryptococcal Antigen Screening and Preemptive Treatment in a US Cohort of Patients With AIDS. (2015) (7)
- The Effect Of Buprenorphine On HIV Viral Suppression. (2021) (6)
- Outcomes of Ritonavir-Boosted Protease Inhibitor Versus Non-Nucleoside Reverse Transcriptase Regimens in a Clinical Practice Cohort (2010) (6)
- Depression and HIV viral non-suppression among people engaged in HIV care in an urban clinic, 2014-2019. (2021) (6)
- Dynamic Visual Display of Treatment Response in HIV-Infected Adults. (2015) (6)
- Brief Report: Reduced Use of Illicit Substances, Even Without Abstinence, Is Associated With Improved Depressive Symptoms Among People Living With HIV (2018) (6)
- Significant decline in heavily treatment experienced persons with HIV with limited antiretroviral treatment options in the US, 2000-2017. (2020) (6)
- LB9. The Effect of Initiating Integrase Inhibitor-based vs. Non-Nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy on Progression to Diabetes among North American Persons in HIV Care (2019) (6)
- Evidence for risk stratification when monitoring for toxicities following initiation of combination antiretroviral therapy (2013) (6)
- Physical activity trends and metabolic health outcomes in people living with HIV in the US, 2008-2015. (2020) (6)
- Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations. (2016) (6)
- Impact of early ART initiation on performance of cross sectional incidence assays. (2020) (5)
- Telemedicine and visit completion among people with HIV during the coronavirus disease 2019 pandemic compared with prepandemic (2021) (5)
- Association between bilirubin, atazanavir, and cardiovascular disease events among people living with HIV across the US. (2019) (5)
- HbA1c, but Not Fasting Glucose or Insulin, Is Independently Associated with Early Pathophysiological Parameters Indicative of Worsening Glycemic Metabolism Post-Transplantation - A Multivariate Analysis (2009) (5)
- First occurrence of diabetes, chronic kidney disease, and hypertension among North American HIV-infected adults, 2000-2013. (2016) (5)
- Rapid Fibrosis Progression Among HIV/Hepatitis C Virus (HCV) Coinfected Adults: Prospective Analysis of 446 Liver Biopsy Pairs (2011) (5)
- COVID-19 and the HIV continuum in people living with HIV enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts (2022) (5)
- Zidovudine and the natural history of AIDS [1] (1991) (5)
- Intersecting Epidemics: Incident Syphilis and Drug Use in Women Living with HIV in the United States (2005-2016). (2019) (4)
- Sensitivity Analyses for Misclassification of Cause of Death in the Parametric G-Formula (2018) (4)
- Cost Effectiveness of Combination HIV Therapy (2012) (4)
- CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa. (2015) (4)
- Association of Infection with Chronic Hepatitis C Virus and Myocardial Infarction in People Living with HIV in the United States. (2019) (4)
- Managing HIV infection in middle aged and older populations (2005) (4)
- Estimating a Set of Mortality Risk Functions with Multiple Contributing Causes of Death (2020) (4)
- Utilization of Pap testing among women living with HIV enrolled in primary care in Baltimore, Maryland: A 10-year longitudinal study, 2005–2014 (2018) (4)
- How does decision complexity affect shared decision making? An analysis of patient-provider antiretroviral initiation dialogue. (2017) (4)
- Heterogeneity in the costs of medical care among people living with HIV/AIDS in the United States. (2019) (4)
- HIV Viremia and Risk of Stroke Among People Living with HIV Who Are Using Antiretroviral Therapy (2021) (4)
- Clinical effectiveness of integrase strand transfer inhibitor-based antiretroviral regimens among adults with human immunodeficiency virus: a collaboration of cohort studies in the United States and Canada. (2020) (4)
- Internalized HIV stigma predicts subsequent viremia in US HIV patients through depressive symptoms and ART adherence. (2020) (4)
- Cervical cancer epidemiology among HIV-infected women in North America (2010) (4)
- Brief Report: Differences in Types of Myocardial Infarctions Among People Aging With HIV. (2021) (4)
- Healthcare economics in HIV (2000) (3)
- Increase in CD4 Count Among New Enrollees in HIV Care in the Modern Antiretroviral Therapy Era (2014) (3)
- The relationship of alcohol and other drug use during the COVID-19 pandemic among people with or at risk of HIV; A cross-sectional survey of people enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts (2022) (3)
- 1125 Hepatotoxicity associated with the antiretroviral therapy (ART) containing protease inhibitors (PIS) with or without pharmacokinetic boosting by low-dose ritonavir (RTV) (2003) (3)
- Longitudinal Associations of Syndemic Conditions with Antiretroviral Therapy Adherence and HIV Viral Suppression Among HIV-Infected Patients in Primary Care. (2021) (3)
- THE EFFECTS OF ROSUVASTATIN ON INSULIN SENSITIVITY AND SECRETION IN NON-DIABETIC RENAL TRANSPLANT RECIPIENTS: 611 (2008) (3)
- Systemic Elevation of Proinflammatory Interleukin-18 in Human Immunodeficiency Virus (HIV)/Hepatitis C Virus (HCV) Coinfection Versus HIV or HCV Monoinfection (2017) (3)
- Clinician Response to Patient Emotion: Impact on Subsequent Communication and Visit Length (2021) (3)
- A49 Ascertainment of the primary end point in the multicenter study of hydroxyurea in sickle cell anemia (MSH) (1996) (3)
- Comparing longitudinal CD4 responses to cART among non-perinatally HIV-infected youth versus adults: Results from the HIVRN Cohort (2017) (3)
- Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort study. (2022) (3)
- Herpes Zoster among Persons Living with HIV in the Current ART Era (2012) (3)
- Virologic outcomes among adults with HIV using integrase inhibitor-based antiretroviral therapy (2021) (3)
- THE EFFECTS OF ROSUVASTATIN ON 51CR-EDTA MEASURD GLOMERULAR FILTRATION RATE AND URINARY ALBUMIN EXCRETION IN NON-DIABETIC RENAL TRANSPLANT RECIPIENTS: 1386 (2008) (3)
- Types of Stroke Among People Living With HIV in the United States. (2021) (3)
- At-Risk Alcohol Use Among HIV-Positive Patients and the Completion of Patient-Reported Outcomes (2018) (3)
- Prevalence of and Factors Associated with Genital and Extragenital Chlamydia and Gonorrhea among Transgender Women in HIV Care in the United States; 2005-2016. (2020) (3)
- Clinic-Level Factors Associated with Retention in Care among People Living with HIV in a Multi-Site United States Cohort, 2010-2016. (2019) (3)
- CD4 count at entry into HIV care and at antiretroviral therapy prescription in the US, 2005-2018. (2020) (3)
- P03 Dose titration in the multicenter study of hydroxyurea in sickle cell anemia (MSH) (1996) (3)
- Short Communication: The Impact of Viral Suppression and Viral Breakthrough on Limited-Antigen Avidity Assay Results in Individuals with Clade B HIV Infection. (2016) (3)
- Study design and participant characteristics of a randomized controlled trial of directly administered antiretroviral therapy in opioid treatment programs (2011) (3)
- Outcomes of Angioplasty vs Thrombolysis by Hospital Angioplasty (2)
- Comparing dynamic monitoring strategies based on evolving CD4 cell counts in virologically suppressed HIV-positive individuals on cART: a prospective observational study in high-income countries (2017) (2)
- High-risk behaviour in a cohort of HIV/hepatitis C coinfected gay and bisexual men commencing hepatitis C treatment (2017) (2)
- THU-395-Hepatitis C elimination by enhancing care and treatment among HIV co-infected individuals (the co-EC study): Real world evidence of decreasing HCV incidence and prevalence (2019) (2)
- Human immunodeficiency virus and lung cancer: differences in presentation and clinical course. (2005) (2)
- The effectiveness of combination antiretroviral therapy in clinical practice (1997) (2)
- Screening for cognitive impairment using a brief, self-administered iPad-based tool in people with HIV seeking adult clinical care: an observational study (Preprint) (2020) (2)
- Statins Are Associated With Decreased Liver Disease Progression in HIV/HCV Co-Infected Adults (2015) (2)
- 1191 BASELINE LIVER STIFFNESS MEASURED BY TRANSIENT ELASTOGRAPHY IS INDEPENDENTLY ASSOCIATED WITH RISK OF END-STAGE LIVER DISEASE AND DEATH AMONG HIV/HCV CO-INFECTED ADULTS (2011) (2)
- Measuring engagement in HIV care: Measurement invariance in three racial/ethnic patient groups. (2020) (2)
- Weight gain post-ART in HIV+ Latinos/as differs in the USA, Haiti, and Latin America (2022) (2)
- Development and Validation of a Multivariable Prediction Model for Missed HIV Health Care Provider Visits in a Large US Clinical Cohort (2021) (2)
- Regional coronary endothelial dysfunction is related to local epicardial fat in HIV+ patients (2016) (2)
- Time Between Viral Loads for People With HIV During the COVID-19 Pandemic (2021) (2)
- Estimating the prevalence of and characteristics associated with prescription opioid diversion among a clinic population living with HIV: Indirect and direct questioning techniques. (2020) (2)
- Reconciling the evaluation of co-morbidities among HIV care patients in two large data systems: the Medical Monitoring Project and CFAR Network of Integrated Clinical Systems (2018) (2)
- Current and Past Immunodeficiency Are Associated With Higher Hospitalization Rates Among Persons on Virologically Suppressive Antiretroviral Therapy for up to 11 Years. (2021) (2)
- HIV Antibody Profiles in HIV Controllers and Persons With Treatment-Induced Viral Suppression (2021) (2)
- CD4/CD8 Ratio and Cancer Risk among Adults with HIV. (2022) (2)
- Brief Report: Insomnia and Risk of Myocardial Infarction Among People With HIV (2022) (2)
- Are clinicians' self-reported empathic concern and perspective-taking traits associated with their response to patient emotions?: Communication Studies. (2020) (2)
- The HIV Index: Using a Patient-Reported Outcome on Engagement in HIV Care to Explain Sub-Optimal Retention in Care and Virologic Control. (2020) (2)
- Weak HIV Antibody Responses in Perinatally Infected Young Adults: Weak HIV Antibody Responses in Perinatally Infected Adults (2017) (2)
- The Patient Reported Outcomes as a Clinical Tool (PROACT) Pilot Study: What Can be Gained by Sharing Computerized Patient-Reported Mental Health and Substance Use Symptoms with Providers in HIV Care? (2021) (2)
- Censoring for loss to follow-up in time-to-event analyses of composite outcomes or in the presence of competing risks. (2019) (2)
- Hematologic, Hepatic, Renal, and Lipid Laboratory Monitoring After Initiation of Combination Antiretroviral Therapy in the United States, 2000–2010 (2013) (2)
- Identifying individuals with virologic failure after initiating effective antiretroviral therapy: The surprising value of mean corpuscular hemoglobin in a cross-sectional study (2010) (2)
- Assessing Antiretroviral Use During Gaps in HIV Primary Care Using Multisite Medicaid Claims and Clinical Data (2017) (2)
- Antiretroviral drug class and anaemia risk in the current treatment era among people living with HIV in the USA: a clinical cohort study (2020) (2)
- Do contemporary antiretrovirals increase the risk of end-stage liver disease? Signals from patients starting therapy in the NA-ACCORD. (2021) (1)
- CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018 (2020) (1)
- CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018 (2020) (1)
- Domestic prevalence of substance use disorders in HIV care settings (2017) (1)
- Unmasking Lymphoma Immune Reconstitution Inflammatory Syndrome Among HIV-Infected Individuals In The Center For AIDS Research Network Of Integrated Clinical Systems (2013) (1)
- Excess mortality after HIV seroconversion has greatly decreased in the past 10 years (2008) (1)
- HIV Managed Care in the Maryland Health Choice Program (2001) (1)
- Predictors of Acute Renal Injury Study (PARIS) among HIV-positive individuals: design and methods (2017) (1)
- Waist-Hip Ratio Is Superior to Body Mass Index as an Assessment of Central Obesity Post-Transplantation (2011) (1)
- 1906. Hospitalization Rates Among Persons With HIV Who Gained Medicaid or Private Insurance in 2014 (2018) (1)
- Hepatitis C treatment success in primary and tertiary care among people with HCV/HIV coinfection (2018) (1)
- Abstract 5729: PSA screening and the decreased risk of prostate cancer among men with AIDS (2010) (1)
- Differentiation of Type 1 and Type 2 Myocardial Infarctions Among HIV-Infected Patients Requires Adjudication Due to Overlap in Risk Factors. (2018) (1)
- Current and Past Immunodeficiency are Associated with Higher Hospitalization Rates among Persons on Virologically Suppressive Antiretroviral Therapy for up to Eleven Years. (2020) (1)
- Current and Past Immunodeficiency are Associated with Higher Hospitalization Rates among Persons on Virologically Suppressive Antiretroviral Therapy for up to Eleven Years. (2020) (1)
- Mortality for adults entering HIV care under universal early treatment compared to the general US population. (2022) (1)
- Influence of Injection Drug Use–Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen Among Virally Suppressed Individuals (2017) (1)
- Integrase Inhibitor Prescribing Disparities in the DC and Johns Hopkins HIV Cohorts (2021) (1)
- Substance use and HIV stage at entry into care among people with HIV (2021) (1)
- Discrimination And Calibration Of The Vacs Index 2.0 For Predicting Mortality Among People With Hiv In North America. (2021) (1)
- Multicenter Development and Validation of a Model for Predicting Retention in Care Among People with HIV (2022) (1)
- Low CD4/CD8 ratio predicts cancer risk among adults with HIV (2021) (1)
- Brief Report: Kidney Dysfunction Does Not Contribute Significantly to Antiretroviral Therapy Modification in Treatment-Naive PLWH Receiving Initial ART (2019) (1)
- The effect of acute infections on HIV-1 viral load and the expression of immune activation markers among HIV-infected adults (1997) (1)
- Antiretroviral Therapy Use, Medication Adherence, and Viral Suppression Among PLWHA with Panic Symptoms (2015) (1)
- The Effect of Buprenorphine on Human Immunodeficiency Virus Viral Suppression (2021) (1)
- Non-tuberculous mycobacteria in HIV-infected patients: geographic, behavioural, and immunological factors – Authors' reply (2005) (1)
- PROPHYLAXIS FOR OPPORTUNISTIC INFECTIONS. AUTHORS' REPLY (1995) (1)
- Cryptosporidiosis in AIDS: Correlates of disease and survival (1997) (1)
- Clinic-based Treatment for Opioid-dependent HIV-infected Patients versus Referral to an Opioid Treatment Program : A Randomized Controlled Trial (2010) (1)
- Risk factors for atrial fibrillation in a multi-center US clinical cohort of people with HIV infection. (2022) (1)
- Tablet-Based Cognitive Impairment Screening for Adults With HIV Seeking Clinical Care: Observational Study (2021) (1)
- A qualitative study of barriers to and facilitators of optimal engagement in care among PLWH and substance use/misuse (2016) (0)
- Response to Internists' Recommendations (2016) (0)
- Reports Self-reported Antiretroviral Therapy in Injection Drug Users (2000) (0)
- Abstract LB-160: Incidence of non-AIDS-defining cancers over time in the post-ART era (2018) (0)
- Alcohol Use Disorder and Recent Alcohol Use and HIV Viral Non-Suppression Among People Engaged in HIV Care in an Urban Clinic, 2014–2018 (2021) (0)
- Risk factors for bacterial pneumonia in MV disease (1997) (0)
- Estimating HIV transmissions in a large U.S. clinic‐based sample: effects of time and syndemic conditions (2021) (0)
- INPATIENT HEALTHCARE UTILIZATION AMONG PATIENTS WHO REQUIRE INTERPRETER SERVICES (2014) (0)
- Non-tuberculous mycobacteria in HIV-infected patients: geographic behavioural and immunological factors. Authors reply [letter] (2005) (0)
- Vancomycin-resistant and vancomycin-sensitive enterococcal bacteremia: A comparison of clinical features and outcomes (1997) (0)
- Maximizing the utility of HIV patient observational databases : proceedings of a symposium held on, August 24, 1996 in Amsterdam, the Netherlands (1998) (0)
- Secular Trends in Breast Cancer Risk Among Women With HIV Initiating ART in North America (2021) (0)
- Communication prior to antiretroviral initiation (2023) (0)
- Anal cancer incidence in men with HIV who have sex with men: are black men at higher risk? (2021) (0)
- Abstract C84: Utilization of cervical cancer screening services by women living with HIV enrolled in primary care at the Moore Clinic of Johns Hopkins Hospital: A 10-year retrospective cohort study (2017) (0)
- A Novel Approach to Race in Patient-Health Care Provider Interactions: Health Care Provider Interracial Anxiety (2012) (0)
- 2492. Differences between Individuals Currently Taking Integrase Inhibitor (INSTI)-based Therapy and Those Not Taking INSTIs in the Era of INSTIs as Recommended First-line Therapy (2019) (0)
- Differences in five year survival after cancer diagnosis between HIV clinic enrollees and the general US population. (2020) (0)
- Response to HAART in women, minorities, and older patients: Results from the CHORUS HIV cohort study (1997) (0)
- Excess mortality after HIV seroconversion has greatly decreased in the past 10 years (2008) (0)
- Discontinuity in Medicaid Coverage Among Young Adults with HIV. (2019) (0)
- Abstract WMP55: HIV Viral Load and Stroke Risk (2020) (0)
- Impact and Correlates of Sub-Optimal Social Support on Antiretroviral Adherence and Clinical Outcomes among Patients in HIV Care (2019) (0)
- HIV-1 diversity after a class switch failure. (2010) (0)
- A05 Treatment guesses by patients and investigators in a double-blind clinical trial (1996) (0)
- Patient-Provider Discussion of High-Risk Sexual Behavior in HIV Care (2011) (0)
- Development and Validation of a Model for Prediction of End-Stage Liver Disease in People With HIV (2021) (0)
- Short Communication: Differences in 5-Year Survival After Cancer Diagnosis Between HIV Clinic Enrollees and the General U.S. Population (2020) (0)
- Reply to Holtzman and Gallagher (2012) (0)
- Health Care Resource Utilization in the Johns Hopkins HIV Clinic Cohort (2001) (0)
- Neutropenia and latrogenic Neutrophil Dysfunction in Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome-Reply (1996) (0)
- Death after diagnosis of noncommunicable disease comorbid conditions, stratified by injection drug use (2019) (0)
- Association between chronic hepatitis C virus infection and myocardial infarction in people living with HIV in the United States (2018) (0)
- 3309 Clinic-Level Factors and Retention in Care among People Living with HIV (PLWH) in a United States (US) Multi-Site Cohort, 2010-2016 (2019) (0)
- Abstract 17129: Low Density Lipoprotein Cholesterol Response After Statin Initiation Among HIV-positive Persons With High Risk for Cardiovascular Disease Events (2016) (0)
- 585. Hospitalization Rates and Diagnoses Vary by Age Group Among Persons with HIV (PWH) in 2014–2015 (2018) (0)
- Correction to: Genetic architecture of cardiometabolic risks in people living with HIV (2021) (0)
- Hepatitis C coinfection and extrahepatic cancer incidence among people living with HIV (2021) (0)
- Current Antiretroviral Treatment Among People With Hiv In The Us: Findings From The Cnics Cohort. (2022) (0)
- The Preoperative Consultation: Response to Internists?? Recommendations (1983) (0)
- THE EFFICACY OF ZIDOVUDINE IS TIME LIMITED. AUTHORS' REPLY (1994) (0)
- Contents page (1995) (0)
- Resource utilization across the continuum of HIV care: An emergency department-based cohort study. (2020) (0)
- A comparison of cancer stage at diagnosis and treatment initiation between enrollees in an urban HIV clinic and SEER (2020) (0)
- Anal cancer incidence in MSM with HIV (2021) (0)
- RisksofRecreationalExposuretoWaterborne PathogensAmongPersonsWithHIV/AIDS inBaltimore,Maryland (2009) (0)
- A learning algorithm for predicting mental health symptoms and substance use. (2020) (0)
- The Impact of Markers of HIV Infection on Change in Liver Stiffness in People With HIV and Hepatitis C Virus Co-infection After Treatment and Cure of Hepatitis C. (2020) (0)
- THU-098-Changes in liver stiffness measurements following DAA treatment among HIV/HCV-coinfected individuals: Does HIV contribute to liver disease after HCV cure? (2019) (0)
- An Inpatient HIV Support Nurse to Promote Engagement in Outpatient HIV Care (2019) (0)
- Reflection and Reaction (2005) (0)
- 994. Risk for Viral Rebound in the Era of U=U; A CNICS Analysis (2020) (0)
- CONTRAST MEDIA COST ANALYSIS. I& II. AUTHORS' REPLY (1994) (0)
- Poor Correlation between Insulin Resistance Indexes and Insulin Sensitivity in Non-Diabetic Renal Transplant Recipients Maintained on Tacrolimus Treatment (2009) (0)
- A comparison of cancer stage at diagnosis and treatment initiation between enrollees in an urban HIV clinic and SEER (2020) (0)
- Coronary artery distensibility is impaired in HIV patients without significant coronary atherosclerosis (2016) (0)
- CHAPTER 45 – Models of Care: HIV Care in the Urban USA (2008) (0)
- CLINICAL ADVANCES IN LIVER, PANCREAS, AND BILIARY TRACT Incidence and Risk Factors for Steatosis Progression in Adults Coinfected With HIV and Hepatitis C Virus (2011) (0)
- Racial, ethnic, and gender disparities in hospitalizations among persons with HIV in the United States and Canada, 2005-2015. (2021) (0)
- P-242 HIV and lung cancer patients: Why such poor survival? (2005) (0)
- Telemedicine Use Among People With HIV in 2021: The Hybrid-Care Environment (2022) (0)
- Antiretroviral Therapy Use and Adherence among PLWHAs who have Panic Disorder (2013) (0)
- Brief Report: Hospitalization Rates Among Persons With HIV Who Gained Medicaid or Private Insurance After the Affordable Care Act in 2014 (2021) (0)
- The impact of M. tuberculosis infection on subsequent disseminated MAC disease in KV-infected persons (1997) (0)
- Unrequited Consults-Reply (1983) (0)
- Reply: (2002) (0)
- Corrigendum to: Clinical Effectiveness of Integrase Strand Transfer Inhibitor-Based Antiretroviral Regimens Among Adults With Human Immunodeficiency Virus: A Collaboration of Cohort Studies in the United States and Canada. (2022) (0)
- Association of the VACS Index With Hospitalization Among People With HIV in the NA-ACCORD (2021) (0)
- PCSK9: A NOVEL MEDIATOR FOR HIV-INDUCED CORONARY ARTERY ENDOTHELIAL DYSFUNCTION (2018) (0)
- Iconographies supplémentaires de l'article : A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users (2011) (0)
- Suitability of HCV treatment in primary care settings for individuals with HIV/hepatitis C coinfection (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Richard D. Moore?
Richard D. Moore is affiliated with the following schools:
